Wikidata

(Q53338003)

English

Efficacy and safety of a new prolonged release formulation of alfuzosin 10 mg once daily versus alfuzosin 2.5 mg thrice daily and placebo in patients with symptomatic benign prostatic hyperplasia. ALFORTI Study Group.

scientific article published in March 2000

In more languages

Statements

title
Efficacy and safety of a new prolonged release formulation of alfuzosin 10 mg once daily versus alfuzosin 2.5 mg thrice daily and placebo in patients with symptomatic benign prostatic hyperplasia. ALFORTI Study Group. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10720857
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/10720857

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53338003&oldid=1613286581"